Better Choice Signs Letter of Intent to Buy Choice Specialty Pharmacy

MT Newswires Live
11 Mar

Better Choice (BTTR) said Tuesday it signed a binding letter of intent to acquire pharmacy services provider Choice Specialty Pharmacy through an option purchase agreement.

The purchase price is based on six times Choice Specialty's fiscal year 2024 adjusted earnings before interest, taxes, depreciation, and amortization of about $4.7 million and the deal will consist of a mix of stock and cash, according to Better Choice.

Shares of Better Choice were down 4% in recent trading.

Price: 1.57, Change: -0.07, Percent Change: -3.98

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

no data

No relevant data is available

If the download button clicks without skipping, click on the top right menu and select "Open in Browser."